Send feedback

MYO7A p.Ala1335Thr

c.4003G>A · rs375066152 · VCV962789

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.2725 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00254%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
4
autosomal dominant nonsyndromic hearing loss 11

Computational evidence

Protein change
AlphaMissense0.2725likely benign
REVEL0.392indeterminate
SaProtLLR -6.42tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 12GERP 1.6, phastCons 1
Regional constrainto/e 0.95unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic
Overall
CADD26.5PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00254% European (non-Finnish) · 30/1,179,906 alleles
Filtering AF 0.0018% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00156%
Overall 0.00242% 39/1,613,814 alleles · very rare exomes 36/1,461,566 · genomes 3/152,248 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00783% 12,778
Remaining individualsnot grpmax-eligible 0.0048% 20,821
European (non-Finnish)grpmax 0.00254% 39,330
South Asian 0.0011% 91,094

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7A
Protein
p.Ala1335Thr
Coding
c.4003G>A
MANE Select
NM_000260
dbSNP
rs375066152
Type
single nucleotide variant
Location
chr11:77192129 (GRCh38)
Gene constraint
LOEUF 0.995 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 77.73 · 1 PDB
Residue 1335
the ferm 1 domain
Full MYO7A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-ala1335thr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown